Director of Cancer Diseases Unit, Rwanda Biomedical Center, Kigali, Rwanda
Dr. François Uwinkindi graduated from the University of Rwanda with a degree in Medicine in 2008, and a Masters in Epidemiology in 2013. Since June 2015, Dr. Uwinkindi is Director of the Cancer Unit in Rwanda Biomedical Center (RBC), an independently governed coordination and implementation arm of the Rwanda Ministry of Health. He is responsible for coordinating all activities related to cancer prevention and control nationwide. Prior to joining the cancer unit, Francois spent five years working in the national HIV control program with different roles and responsibilities in prevention, care and treatment, monitoring and evaluation, and clinical research. He has published four manuscripts in peer-reviewed journals as first author and co-author. He is now poised to develop and implement a national cancer control plan, establish a national cancer registry, roll out cervical cancer screening and breast cancer early detection services countrywide, upgrade cancer diagnosis and treatment facilities in the country, and also promote oncology-related research.
Doctoral Candidate, University of Saskatchewan, Canada
Dr. Kelechi Eguzo is a General Practitioner in oncology and a doctoral candidate at the University of Saskatchewan, Canada. Kelechi has been involved in cancer control and medical research since graduating from the University of Calabar in 2007. Through mentorship at the Nigerian Christian Hospital, University of Uyo Teaching Hospital, and the British Columbia Cancer Agency, he has gained experience in cancer management as a family physician. Most notable among Kelechi’s contribution to global oncology is the book ‘Where there is no oncologist’. Now in its second edition, this international manual provides guidance on how to administer chemotherapy and follow-up with cancer patients in resource-limited settings.
Dr. Eguzo is involved in training physicians and nurses in Nigeria through volunteering with the American Society of Clinical Oncology (ASCO). He has facilitated three ASCO conferences in Abia and Akwa Ibom States. Next February, he will lead the Cancer Control in Primary Care course for ASCO in Anambra State. He also serves on the ASCO Working Group for Multidisciplinary Cancer Management Course. Kelechi has earned several awards, including: International Development and Education Award (ASCO 2011) and outstanding abstract award (Cancer Research UK, 2017). He has published several peer-reviewed articles. His doctoral research is focused on developing a cancer control framework for Abia State. Kelechi is leading the Marjorie Bash Cancer Center project (Aba, Nigeria).
Deputy Director, Kazakh Institute of Oncology and Radiology, Almaty, Kazakhstan
Dr. Dauren Adilbay is Deputy Director of the Kazakh Institute of Oncology and Radiology (KazIOR) and specialises in head and neck cancer surgery. Dr Adilbay completed his medical schooling and post-graduation at the Almaty State Medical University. He was adjudged the best intern and best postgraduate during his tenure in KazIOR. Later, he decided to work in the field of head and neck surgical oncology and received his residency training at the N.N. Blokhin Cancer Center in Moscow, Russia. In 2009, he was awarded ASCO’s IDEA grant to visit the MD Anderson Cancer Center and ASCO’s annual meeting. He has authored 12 articles in peer-reviewed journals and a book chapter. From 2012 to 2014, he worked as Department Chief of head and neck oncology in Astana Oncology Center, Kazakhstan. Since 2015, he is the Deputy Director responsible for science and education at KazIOR. Dr. Adilbay also has a Masters in Public Health and is actively involved as a consultant and organises public campaigns held by different local and international NGOs.
Executive Director, Uganda Cancer Society, Kampala, Uganda
Paul Ebusu holds a Masters in Public Health from the University of Pretoria. He has a certificate in Tobacco Control Leadership and in Monitoring and Evaluation of Health Programs from Measure Evaluations. He has done research in tobacco control with an interest in implementation science. Paul has over 7 years of experience in tobacco and cancer control advocacy. He has experience in program development and implementation, monitoring and evaluation, and was part of the team that evaluated the African Tobacco Control Consortium (ATCC) project. Paul initiated and co-founded the Tobacco Industry Documents Research in Africa (TIDRA) project, implemented by the Centre for Tobacco Control in Africa (CTCA) and the Department of Anthropology at the University of Denver. Currently, Paul is the Executive Director of Uganda Cancer Society and a member of the Steering Committee for the establishment of the Uganda National Cancer Control Program. He is a member of the Uganda Technical Working Group on NCDs and Cancer Diagnostics and the World Cancer Day 2018 Advisory Working Group.
CEO, Instituto Desiderata, Rio de Janeiro, Brazil
Roberta has always worked as a manager for social organisations. She has a deep interest in qualifying public systems as a way to reach more people, especially those most in need. Since 2011, she has been the CEO of Instituto Desiderata which aims to strengthen the public health system in order to promote early diagnosis and treatment for children and adolescents with cancer in Rio de Janeiro, Brazil. She is also a member of the Executive Secretariat of Unidos pela Cura (United towards a Cure), a program designed in conjunction with paediatric oncology hospitals, government administrators, and civil society. This initiative is divided into three strategies: education (capacity building for healthcare professionals in order to ensure early detection of childhood cancers), an organized referral flow (suspected cases of paediatric cancers to be diagnosed in 72 hours), and an information system (a portal providing information and management tools.
Roberta has coordinated and organised the last three editions of the Rio de Janeiro Forum of Paediatric Oncology. In 2017, it attracted more than 300 professionals including managers, policy makers, health professionals, national and international cancer specialists, and civil society institutions.
Assistant Professor, Naef K. Basile Cancer Institute, American University of Beirut, Beirut, Lebanon
Dr. Youssef Zeidan is Assistant Professor of Radiation Oncology and Residency Program Director at the American University of Beirut. He holds a dual MD/PhD degree from the Medical University of South Carolina (MUSC). He completed his internship at Indiana University School of Medicine before joining the prestigious radiation oncology residency program at Stanford University in 2010. He graduated from Stanford in 2014 and successfully completed his American Board of Radiology-Radiation Oncology section, before joining the Department of Radiation Oncology at the University of Miami, Miller School of Medicine as an Assistant Professor and Director of the radiobiology program.
Youssef’s research work focuses on the role of lipids in cellular injury and mitigation of radiation toxicity. He has several publications on the role of radiotherapy in head and neck and breast cancers. He also published on issues related to the Radiation Oncology discipline both in the USA and in Lebanon. His work has been recognised by several honours and awards by professional societies.
Associate Professor, Tata Memorial Hospital, Mumbai, India
Dr. Supriya Jayant Sastri is a Professor in Radiation Oncology at Tata Memorial Hospital, Mumbai, India. Dr. Sastri joined as faculty in 2009 and has focused on testing high precision radiation and new molecular pathways to improve outcomes of cervical cancer.
Supriya has received multiple national and international research awards and has served as faculty at international forums like ASTRO, ESTRO, and IAEA. She is a member of the ASTRO International Education Committee and leads a joint initiative on teaching clinical trial methodology in India. She coordinates translational research for an international cervical cancer study (EMBRACE) and leads an initiative to homogenise cervical cancer treatment in India. While she focuses on advancing research, she recognises that the majority of cervical cancer deaths in LMICs are due to limited or delayed access to treatment, lack of adequate training, and suboptimal implementation. While costs of treatment are escalating internationally, she strongly believes that cervical cancer mortality can be reduced by effective implementation of simple radiation techniques and by improving access to brachytherapy. Supriya wants to work towards reducing cervical cancer mortality by robust implementation of standard of care treatment and improving access to brachytherapy within LMICs.